Close
ACHEMA MIDDLE EAST 2026

Memo Therapeutics Begins Landmark BK Virus Therapy Trial

Memo Therapeutics has brought to notice the start of a clinical trial in renal transplant patients to treat BK polyomavirus (BKV) infection.The safety, tolerability, and...

Jubilant Gets $146.6M To Expand Its Injectables Production

Jubilant HollisterStier has grabbed a $146.6 million contract from the US government, continuing to ride the industrial expansion wave created by the COVID-19 business...

Sandoz Initiates New Worldwide Health Inequality Movement

Sandoz, a biosimilars manufacturer, has announced the beginning of a new global campaign to combat global health disparities. By harnessing the '4 As' of...

NRG Earns £2.68m Grant Boost For Neurodegenerative Illness

NRG Therapeutics, a neuroscience firm, has been presented with the Biomedical Catalyst award. The £2.68 million package will be used to advance the pre-clinical...

New Guidelines To Accelerate The Pace of Paediatric Drugs

A new approach for extrapolating clinical trial data using adult research aims to speed up and lower the cost of testing and approval of...

Scientists Uncover Sea Corals That Can Help Fight Cancer

The ocean below is filled with riddles, but scientists have recently discovered one of its best-kept mysteries. For the past 25 years, researchers have...

Dr. Reddys Boasts Strong Russia Sales While Big Pharma Pulls

While many western biopharma businesses have shied away from Russia since its invasion of Ukraine, some of those in India have stepped in to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...